CG
NVCR icon

Colony Group’s NovoCure NVCR Stock Holding History

Colony Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.45M Sell
89,926
-2,827
-3% -$81.5K 0.02% 381
2023
Q2 		$3.85M Buy
92,753
+88,821
+2,259% +$5.52M 0.05% 261
2023
Q1 		$236K Sell
3,932
-99,831
-96% -$7.98M ﹤0.01% 711
2022
Q4 		$7.61M Buy
103,763
+11,970
+13% +$901K 0.11% 184
2022
Q3 		$6.97M Sell
91,793
-303
-0.3% -$23.6K 0.12% 163
2022
Q2 		$6.4M Buy
92,096
+4,347
+5% +$327K 0.11% 175
2022
Q1 		$7.27M Buy
87,749
+5,181
+6% +$382K 0.11% 167
2021
Q4 		$6.2M Buy
82,568
+786
+1% +$78.9K 0.11% 160
2021
Q3 		$9.5M Sell
81,782
-6,651
-8% -$1.01M 0.18% 103
2021
Q2 		$19.6M Sell
88,433
-5,773
-6% -$1.12M 0.39% 69
2021
Q1 		$12.5M Sell
94,206
-4,164
-4% -$659K 0.26% 88
2020
Q4 		$17M Sell
98,370
-3,088
-3% -$423K 0.39% 67
2020
Q3 		$11.3M Sell
101,458
-4,825
-5% -$386K 0.29% 82
2020
Q2 		$6.3M Sell
106,283
-4,326
-4% -$285K 0.18% 114
2020
Q1 		$7.45M Sell
110,609
-4,370
-4% -$345K 0.24% 108
2019
Q4 		$9.69M Sell
114,979
-3,708
-3% -$299K 0.24% 110
2019
Q3 		$8.88M Sell
118,687
-19,940
-14% -$1.59M 0.28% 99
2019
Q2 		$8.77M Buy
+138,627
New +$7.02M 0.28% 97

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Colony Group's NVCR Position: Q3 2023 in Review

Colony Group reduced its NovoCure (NVCR) stake by 3% in Q3 2023, selling an estimated $81.5K and leaving 89,926 shares worth $1.45M. The position accounts for 0.02% of the portfolio, ranked #381.

Colony Group first reported a position in NVCR in Q2 2019 and has held it in 18 quarters since. The position peaked at $19.6M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Colony Group held 89,926 shares of NovoCure worth $1.45M as of Q3 2023.
  • Colony Group sold 2,827 NovoCure shares in Q3 2023, an estimated $81.5K.
  • NovoCure made up 0.02% of Colony Group's portfolio in Q3 2023, its #381 holding.
  • Colony Group first reported a position in NovoCure in Q2 2019 and has held it in 18 quarters since.
  • Colony Group's NovoCure position peaked at $19.6M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.